🇺🇸 Xomolix 1.25 mg in United States

Xomolix 1.25 mg (Xomolix 1.25 mg) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Xomolix 1.25 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Xomolix 1.25 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Xomolix 1.25 mg in United States?

Medical University of Gdansk is the originator. The local marketing authorisation holder may differ — check the official source linked above.